Predictors of Incisional Hernia After Cytoreductive Surgery and HIPEC: A Retrospective Analysis

Daniela Di Pietrantonio1, Fabrizio D'Acapito1, Massimo Framarini1

  • 1General and Oncologic Surgery, Morgagni-Pierantoni Hospital, AUSL Romagna, 47121 ForlìItaly, Italy.

PubMed

Insights

Incisional hernias are common after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Hypertension is a key risk factor, but surgical details were not significant predictors.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Abdominal Surgery

Background:

  • Incisional hernia is a frequent complication post-cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
  • Identifying risk factors is crucial for preventing this complication.

Purpose of the Study:

  • To determine patient and surgical factors predicting incisional hernia development after CRS and HIPEC.
  • To inform targeted preventive strategies for high-risk individuals.

Main Methods:

  • Retrospective analysis of 122 patients who underwent CRS and HIPEC.
  • Logistic regression models were employed to identify significant predictors of incisional hernia.

Main Results:

  • The incidence of incisional hernia was 23.8%.
  • Hypertension emerged as an independent risk factor for incisional hernia.
  • Peritoneal Cancer Index (PCI), operative duration, and abdominal closure technique did not show significant association.

Conclusions:

  • Preoperative identification of patients at higher risk for incisional hernia is possible.
  • Preventive measures like prophylactic mesh placement and vigilant postoperative monitoring should be considered for at-risk patients.